-
Increases in Frailty Following Hospitalization With COVID-19: An Analysis of Claims and Annual Health Check Data
Sep 9, 2025, 16:22 PM -
Leveraging a Multicountry Real-World Data Observatory to Monitor Respiratory Tract Infections and Evaluate Public Health Interventions in Europe
Sep 9, 2025, 16:22 PM -
Reimbursement Challenges for ATMPs in EU5: Learnings From Product Withdrawals and Implications for Future Development of Innovative Therapies
Sep 9, 2025, 16:22 PM -
Do Health Technology Assessments (HTA) Consider Racial Health Inequalities? A Case Study of NICE HTAs for Chronic Kidney Disease Hypertension and Diabetes
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Pancreatic Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Qualitative Evaluation of an AI Tool for Opportunistic Detection of Vertebral Fractures in the National Health Service
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Mixed-Approach Maternal RSVpreF/Infant Nirsevimab Immunization vs. Nirsevimab Alone for Prevention of Respiratory Syncytial Virus in Spain
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life Measured by EQ-5D Utility Among Patients With TGCT: A Trial-Based Analysis of EQ-5D Data From Patients in the MOTION Trial
Sep 9, 2025, 16:22 PM -
Digital Divide in Health Information Seeking: Rural and Urban Differences in the Use of Online Health Tools in the United States
Sep 9, 2025, 16:22 PM -
Screening for Chronic Kidney Disease (CKD): A Systematic Review and Meta-Analysis of Trials
Sep 9, 2025, 16:22 PM -
Antibody-Drug Conjugates in Colorectal Cancer: A Scoping Review of Current Evidence and Emerging Clinical Trends
Sep 9, 2025, 16:22 PM -
Indirect Treatment Comparisons in Economic Evaluations Submitted to the French Health Authority (CEESP) Since 2014
Sep 9, 2025, 16:22 PM -
A Method to Estimate Causally Related Cost Savings of a Preventive Intervention: An Analysis Using the Wellness-Star☆ Database
Sep 9, 2025, 16:22 PM -
The Effects of Disease Modifying Anti-Rheumatic Drugs (DMARDs) on Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Network Meta-Analyses
Sep 9, 2025, 16:22 PM -
Real-World Effectiveness, Safety Economic Impact, and Humanistic Outcomes of Bispecific Antibodies (BsAbs) in Third-or-Later-Line (3L+) Treatment of Relapsed/Refractory (R/R) Large B-cell Lymphoma (LBCL): A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Integrating Patient Perspectives Into Drug Reimbursement Decisions: Insights From Taiwan’s Deliberative HTA Process
Sep 9, 2025, 16:22 PM -
Developing an HER-Based Multifeature Machine Learning Model to Identify Lung Cancer Subtype
Sep 9, 2025, 16:22 PM -
What About a Latent Cure Model? Assessing Cure Models’ Performance in Pediatric Acute Lymphoblastic Leukemia Treated With Tisagenlecleucel
Sep 9, 2025, 16:22 PM -
Integrating PROMs Into Real-World Ophthalmology Practice: A Pilot Project on Neovascular AMD
Sep 9, 2025, 16:22 PM -
Diagnostic Patterns and Subtype Overlap in Idiopathic Inflammatory Myopathies: A Retrospective Claims-Based Cohort Study
Sep 9, 2025, 16:22 PM
